Hasil Pencarian - Hong-hong Yan
- Menampilkan 1 - 20 hasil dari 27
- Ke Halaman Berikutnya
-
1
Combined Cellular Automaton Model for Dynamic Recrystallization Evolution of 42CrMo Cast Steel oleh Yi-Na Guo, Yong-Tang Li, Wen-Yan Tian, Hui-Ping Qi, Hong-Hong Yan
Diterbitkan 2018-10-01
Artikel -
2
-
3
-
4
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients oleh Hong‐xia Tian, Zhi‐hong Chen, Guang‐Ling Jie, Zhen Wang, Hong‐hong Yan, Si‐pei Wu, Shui‐lian Zhang, Dan‐xia Lu, Xu‐chao Zhang, Yi‐long Wu
Diterbitkan 2023-01-01
Artikel -
5
-
6
Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation oleh Jie Huang, Shi‐Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu‐Qing Chen, Jun‐Wei Su, Hong‐Hong Yan, Hua‐Jun Chen, Jin‐Ji Yang, Junjian Wang, Yi‐Long Wu
Diterbitkan 2024-05-01
Artikel -
7
Three‐dimensional printed navigational template for localizing small pulmonary nodules: A case‐controlled study oleh Rui Fu, Yun‐Fei Chai, Jia‐Tao Zhang, Tao Zhang, Xiao‐Kun Chen, Song Dong, Hong‐Hong Yan, Xue‐Ning Yang, Mei‐Ping Huang, Yi‐Long Wu, Jian Zhuang, Wen‐Zhao Zhong
Diterbitkan 2020-09-01
Artikel -
8
Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial oleh Qing Zhou, Jin-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang, Hong-Hong Yan, Chong-Rui Xu, Jian Su, Hua-Jun Chen, Hai-Yan Tu, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu
Diterbitkan 2016-09-01
Artikel -
9
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort stud oleh Yi-Long Wu, De-Hua Wu, Si-Cong Ma, Xin-Ran Tang, Shuai Kang, Qiang John Fu, Chuan-Hui Cao, He-San Luo, Yu-Han Chen, Hong-Bo Zhu, Hong-Hong Yan, Zhong-Yi Dong
Diterbitkan 2020-06-01
Artikel -
10
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. oleh She-Juan An, Zhi-Hong Chen, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, Jin-Ji Yang, Qing Zhou, Xue-Ning Yang, Ling Huang, Ji-Lin Guan, Qiang Nie, Hong-Hong Yan, Tony S Mok, Yi-Long Wu
Diterbitkan 2012-01-01
Artikel -
11
Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study oleh Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Diterbitkan 2024-02-01
Artikel -
12
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism oleh Si‐Yang Liu, Jia‐Ying Zhou, Wen‐Feng Li, Hao Sun, Yi‐Chen Zhang, Hong‐Hong Yan, Zhi‐Hong Chen, Chun‐Xiang Chen, Jun‐Yi Ye, Jin‐Ji Yang, Qing Zhou, Xu‐Chao Zhang, Yi‐Long Wu
Diterbitkan 2020-03-01
Artikel -
13
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer oleh Lingling Yang, Qing Zhou, Jian Su, Yi-Long Wu, Zhi-Hong Chen, Wen-zhao Zhong, Hong-Hong Yan, Qing Gou, Xue-Wu Wei, Xiao-Rong Yang, Jia-Yi Deng, Ming-Yi Yang, Jia-Qi Liu, Chong-Rui Xu
Diterbitkan 2023-07-01
Artikel -
14
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression oleh Rui-Lian Chen, Jun Zhao, Xu-Chao Zhang, Na-Na Lou, Hua-Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai-Yan Tu, Wen-Zhao Zhong, Hong-Hong Yan, Wei-Bang Guo, Yi-Long Wu, Jin-Ji Yang
Diterbitkan 2018-11-01
Artikel -
15
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients oleh Zhen Wang, Xu-Chao Zhang, Wei-Neng Feng, Li Zhang, Xiao-Qing Liu, Wei-Bang Guo, Yan-Ming Deng, Qing-Feng Zou, Jin-Ji Yang, Qing Zhou, Bin-Chao Wang, Hua-Jun Chen, Hai-Yan Tu, Hong-Hong Yan, Yi-Long Wu
Diterbitkan 2023-04-01
Artikel -
16
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma oleh Hao Sun, Si-Yang Liu, Jia-Ying Zhou, Jin-Tian Xu, Huang-Kai Zhang, Hong-Hong Yan, Jiao-Jiao Huan, Ping-Ping Dai, Chong-Rui Xu, Jian Su, Yan-Fang Guan, Xin Yi, Rong-Shan Yu, Wen-Zhao Zhong, Yi-Long Wu
Diterbitkan 2020-10-01
Artikel -
17
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors oleh Lun-Xi Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu, Hao Sun, Mei-Mei Zheng, Jia-Ying Zhou, Jia-Tao Zhang, Xu-Chao Zhang, Qing Zhou, Wen-Zhao Zhong, Jin-Ji Yang, Hai-Yan Tu, Jian Su, Hong-Hong Yan, Yi-Long Wu
Diterbitkan 2021-11-01
Artikel -
18
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer oleh Kai‐Cheng Peng, Jun‐Wei Su, Zhi Xie, Han‐Min Wang, Mei‐Mei Fang, Wen‐Feng Li, Yu‐Qing Chen, Xu‐Hui Guan, Jian Su, Hong‐Hong Yan, Xu‐Chao Zhang, Hai‐Yan Tu, Qing Zhou, Hua‐Jun Chen, Yi‐Long Wu, Jin‐Ji Yang
Diterbitkan 2022-06-01
Artikel -
19
Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images oleh Ri-qiang Liao, An-wei Li, Hong-hong Yan, Jun-tao Lin, Si-yang Liu, Jing-wen Wang, Jian-sheng Fang, Hong-bo Liu, Yong-he Hou, Chao Song, Hui-fang Yang, Bin Li, Ben-yuan Jiang, Song Dong, Qiang Nie, Wen-zhao Zhong, Yi-long Wu, Xue-ning Yang
Diterbitkan 2022-10-01
Artikel -
20
Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients oleh Jing‐Hua Chen, Xiang‐Peng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hong‐Ping Zheng, Ze‐Xin Chen, Xin Chen, Meng‐Meng Song, Xin Yi, Pan‐Song Li, Yan‐Fang Guan, Gang Li, Chu‐Xia Deng, Rafael Rosell, Yi‐Long Wu, Wen‐Zhao Zhong
Diterbitkan 2020-08-01
Artikel